Aida Pharmaceuticals Inc. Stock Analysis AIDA
AiDa Pharmaceuticals, Inc. engages in the development, production, and distribution of pharmaceutical products. The company is headquartered in Hangzhou, Zhejiang and currently employs 450 full-time employees. The company went IPO on 2006-07-05. Through its subsidiaries, the Company has nine production lines for the manufacture of antibiotics, cardiovascular and anti-tumor drugs in various forms, including injectable powder, injectable liquid, capsules, tablets and ointments.
Read More Aida Pharmaceuticals Inc (AIDA) Chart
Key Statistics of Aida Pharmaceuticals Inc (AIDA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
500.00P/E Ratio (TTM)
0.0052 Week Range
Market Cap
10.00KAvg. Volume
500.00Dividend Yield
-Financial Metrics & Statements of Aida Pharmaceuticals Inc (AIDA)
FAQ's for Aida Pharmaceuticals Inc (AIDA)
- According to Musaffa’s Shariah screening methodology, Aida Pharmaceuticals Inc (AIDA) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.